Morgan Stanley (MS) uses April 8, 2026 prospectus addendum for Series I market-making

Rhea-AI Filing Summary

Morgan Stanley filed a prospectus addendum and accompanying prospectus supplement and prospectus dated April 8, 2026 for Global Medium-Term Notes, Series I. The addendum permits use of these documents in connection with market-making transactions in notes originally issued under earlier, similar documents.

Key Figures

Registration Statement No.: 333-293641 Document date: April 8, 2026 Series: Global Medium-Term Notes, Series I

3 metrics

Registration Statement No. 333-293641 covering prospectus addendum

Document date April 8, 2026 prospectus addendum and accompanying prospectus supplement and prospectus

Series Global Medium-Term Notes, Series I securities described in the prospectus addendum

Key Terms

prospectus addendum, prospectus supplement, market-making transactions, Global Medium-Term Notes, Series I

4 terms

prospectus addendum regulatory

"Prospectus Addendum to the Prospectus Supplement dated April 8, 2026"

prospectus supplement regulatory

"accompanying prospectus supplement dated April 8, 2026 relating to Global Medium-Term Notes, Series I"

A prospectus supplement is an additional document provided alongside a company's main offering details, offering updated or extra information about a specific financial product being sold. It helps investors understand the latest terms, risks, and details of the investment, similar to how an update or revision clarifies or expands on original instructions, ensuring they have current and complete information before making a decision.

market-making transactions market

"used in connection with market-making transactions of notes"

Global Medium-Term Notes, Series I financial

"Global Medium-Term Notes, Series I will, and other affiliates may, use this prospectus addendum"

Offering Details

other

Offering

Offering Type other

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Filed Pursuant to Rule 424(b)(3)
Registration Statement No. 333-293641

Prospectus Addendum to 

the Prospectus Supplement dated April 8, 2026 and
the accompanying Prospectus dated April 8, 2026

GLOBAL MEDIUM-TERM NOTES, SERIES I

Morgan Stanley & Co. LLC will, and other affiliates of Morgan Stanley may, use this prospectus addendum, the accompanying prospectus supplement dated April 8, 2026 relating to Global Medium-Term Notes, Series I and/or the accompanying prospectus dated April 8, 2026 in connection with market-making transactions of notes that were originally issued under a similar prospectus supplement for Global Medium-Term Notes, Series I, with a date earlier than April 8, 2026, and/or a similar prospectus with a date earlier than April 8, 2026. We refer below to such earlier prospectus supplement as the “earlier prospectus supplement” and such earlier prospectus as the “earlier prospectus.”

When this prospectus addendum, the accompanying prospectus supplement dated April 8, 2026 relating to Global Medium-Term Notes, Series I and the accompanying prospectus dated April 8, 2026 are used in connection with a market-making transaction, you should note that the accompanying prospectus supplement dated April 8, 2026 relating to Global Medium-Term Notes, Series I supersedes the earlier prospectus supplement, and the accompanying prospectus dated April 8, 2026 supersedes the earlier prospectus. When you read the prospectus supplement or pricing supplement with the specific terms of the offered notes, please note that all references in it to the earlier prospectus supplement should instead refer to the accompanying prospectus supplement dated April 8, 2026 relating to Global Medium-Term Notes, Series I, and all references in it to the earlier prospectus should instead refer to the accompanying prospectus dated April 8, 2026.

You should read the terms of the accompanying prospectus supplement or pricing supplement, which describes the specific terms of the offered notes, together with the accompanying prospectus supplement dated April 8, 2026 relating to Global Medium-Term Notes, Series I and/or the accompanying prospectus dated April 8, 2026.

The offered notes are not deposits or savings accounts and are not insured by the Federal Deposit Insurance Corporation or any other governmental agency or instrumentality, nor are they obligations of, or guaranteed by, a bank.

MORGAN STANLEY

April 8, 2026

FAQ

What does Morgan Stanley's April 8, 2026 prospectus addendum do (MS)?

It permits use of updated prospectus documents for market-making transactions. The addendum and the accompanying April 8, 2026 prospectus supplement and prospectus supersede earlier versions for Global Medium-Term Notes, Series I when used in market-making activity.

Are the Global Medium-Term Notes insured or bank obligations (MS)?

No — the notes are not bank deposits or FDIC insured. The filing states the offered notes are not deposits, not insured by the FDIC or any governmental agency, and are not obligations or guarantees of a bank.

When should investors read the April 8, 2026 prospectus supplement for Series I (MS)?

Read the April 8, 2026 prospectus supplement with any pricing supplement for specific terms. The supplement contains the specific terms of the offered notes and replaces earlier prospectus language referenced in pricing documents.

Does the addendum change the terms of previously issued notes (MS)?

The addendum supersedes earlier prospectus language for market-making use but does not state changes to original note terms. It instructs users to read the specific pricing supplement with the April 8, 2026 supplement and prospectus for the offered notes' terms.